financetom
Business
financetom
/
Business
/
Madison Metals Announces Non-Brokered Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Madison Metals Announces Non-Brokered Private Placement
Mar 12, 2024 1:08 PM

03:47 PM EDT, 03/12/2024 (MT Newswires) -- Madison Metals Inc. ( MMTLF ) announced Tuesday that it will be proceeding with a private placement financing consisting of the sale of up to 10 million units in the capital of the company at a price of $0.35 per unit for aggregate gross proceeds of a minimum of $1 million and a maximum of $3.5 million.

Each unit consists of one common share and one-half common share purchase warrant.

Each full warrant entitles the holder thereof to purchase one Common Share in the capital of the company for a price of $0.50 for a period of eighteen months from the date of the closing.

Madison Metals Inc. ( MMTLF ) is an upstream mining and exploration company focused on sustainable uranium production in Namibia and Canada.

Price: 0.39, Change: +0.02, Percent Change: +6.94

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Apr 25, 2024
(Reuters) -GlaxoSmithKline sued Pfizer ( PFE ) and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer ( PFE ) and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed more than a decade...
TransUnion Q1 Adjusted Earnings, Revenue Gain; Sets Q2 Outlook; Raises 2024 Guidance; Shares Rise
TransUnion Q1 Adjusted Earnings, Revenue Gain; Sets Q2 Outlook; Raises 2024 Guidance; Shares Rise
Apr 25, 2024
09:57 AM EDT, 04/25/2024 (MT Newswires) -- TransUnion ( TRU ) reported Q1 adjusted earnings Thursday of $0.92 per diluted share, up from $0.80 a year earlier. Analysts polled by Capital IQ expected $0.81. Revenue for the quarter ended March 31 was $1.02 billion, up from $940.3 million a year earlier. Analysts surveyed by Capital IQ expected $978.0 million. TransUnion...
American Airlines Swings to Q1 Adjusted Loss While Revenue Advances; Sets Q2 Adjusted Profit Outlook
American Airlines Swings to Q1 Adjusted Loss While Revenue Advances; Sets Q2 Adjusted Profit Outlook
Apr 25, 2024
09:36 AM EDT, 04/25/2024 (MT Newswires) -- American Airlines ( AAL ) reported a Q1 adjusted loss Thursday of $0.34 per diluted share, swinging from earnings of $0.05 a year earlier. Analysts polled by Capital IQ expected a loss of $0.29. Revenue for the quarter ended March 31 was $12.57 billion, up from $12.19 billion a year earlier. Analysts surveyed...
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
Apr 25, 2024
Thursday, Sanofi SA ( SNY )  reported first-quarter operating income of 2.8 billion euros, down 14.7% Y/Y and 4.2% on constant currency. The French drugmaker reported adjusted EPS of $0.97 (1.78 euros), beating the consensus estimate of $0.94. Also Read: In Heart Burn Drug Zantac’s Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster. The company reported first-quarter sales of $11.36 billion (10.5 billion euros),...
Copyright 2023-2026 - www.financetom.com All Rights Reserved